Skip to main content Back to Top

Finding Hidden Stroke Risk: Screening for Atrial Fibrillation

Broadcast Date: April 29, 2022


Subscribe on iTune PodcastsListen on Google PlaySubscribe to Stitcher Podcasts Listen on Spotify Subscribe to TuneIn PodcastsSubscribe to iHeartRadio

Atrial fibrillation is the most common abnormal heart rhythm and has tripled in prevalence of the last 50 years. Approximately 20% of patients with atrial fibrillation may not even know that they have the arrhythmia. This podcast episode will provide insight into the importance of undiagnosed atrial fibrillation and will give practical tips to the pharmacist interested in developing a screening program for identifying undiagnosed atrial fibrillation.

To learn more, visit


James KalusJames S. Kalus, PharmD, FASHP, is Director of Pharmacy at Henry Ford Health System in Detroit, Michigan where he is responsible for planning, implementing, and managing all pharmacy services related to patient care including staff training and development, and pharmacy research. Dr. Kalus also serves as Program Director for the postgraduate year one (PGY1) residency at Henry Ford Hospital and is adjunct assistant professor of pharmacy and medicine at Wayne State University. In his research, Dr. Kalus has focused on cardiovascular disease, including the pathophysiology of atrial fibrillation (AF) occurring after cardiac surgery, novel strategies for the treatment and prevention of AF, practice-based research related to anticoagulation and implementation science related to clinical pharmacy services.

Devin LavenderDevin Lavender, PharmD, BCPS, BCACP is Clinical Assistant Professor at the University of Georgia College of Pharmacy in Athens, Georgia where he practices in Ambulatory Care and chronic disease management at the Athens Community Based Outpatient Clinic affiliated with the Charlie Norwood VA Medical Center. Dr. Lavender obtained his PharmD degree from The University of Georgia College of Pharmacy. He completed a PGY1 Pharmacy Practice Residency at the Memphis VA Medical Center followed by a PGY2 Ambulatory Care Specialty Residency at the University of Georgia College of Pharmacy in conjunction with the Charlie Norwood VA Medical Center.


Relevant Financial Relationship Disclosures

No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company.

As defined by the Standards of Integrity and Independence in Accredited Continuing Education definition of ineligible company. 


More in this series

Finding Undiagnosed Atrial Fibrillation: Why, What, Who and How

The Time is Now: Equity in the Prescribing of DOACs for NVAF

Don’t Skip a Beat: Practical Considerations When Choosing an Anticoagulant for Nonvalvular Atrial Fibrillation

Hidden in Plain Sight: Does My Patient Have Nonvalvular Atrial Fibrillation?

Shining a Light on Undiagnosed Nonvalvular Atrial Fibrillation: A Case-based Approach to Care


The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Provided by ASHP
Supported by an educational grant from the Bristol Myers Squibb and Pfizer Alliance